Acute on chronic intestinal pseudoobstruction responds to neostigmine.
Borgaonkar
M R
MR
Division of Gastroenterology, McMaster University, Hamilton, Ontario, Canada.
Lumb
B
B
D000208:Acute Disease; D000328:Adult; D000639:Amitriptyline / Q000009:adverse effects / Q000031:analogs & derivatives; D018680:Cholinergic Antagonists / Q000009:adverse effects; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D002908:Chronic Disease; D005260:Female; D006801:Humans; D007418:Intestinal Pseudo-Obstruction / Q000188:drug therapy*; D018814:Multiple Endocrine Neoplasia Type 2b / Q000150:complications; D009388:Neostigmine / Q000627:therapeutic use*
D018680:Cholinergic Antagonists; D002800:Cholinesterase Inhibitors; D000639:Amitriptyline; D009388:Neostigmine; C004704:cyclobenzaprine